By early 2026, FDA had publicly announced enforcement actions against multiple compounded GLP-1 telehealth platforms, and in April 2026 formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list - with a public comment period running through June 2026
Post-Discontinuation Monitoring : Test 6-8 weeks after stopping to assess how your microbiome is adapting and prevent metabolic rebound
Infection risks Like any procedure that punctures the skin, tattooing carries some risk of infection
Unlike traditional rhinoplasty, which involves reshaping bone and cartilage, non-surgical rhinoplasty uses dermal fillers to create volume and smoothness where needed
Winning the new shape of demand will require targeting and appealing to each segment differently, rather than treating GLP-1 users as a single, homogeneous consumer group, says Lauren Taylor, a BCG managing director and senior partner who leads CCI globally
A study looked at the nutritional effects of trimethylamine N -oxide and LC on reducing obesity in mice caused by a HFD